Episode 169: May 2019 Retinal Physician at ARVO 2019
Drs. Ajay Kuriyan and Glenn Yiu join the program to discuss articles from the May 2019 issue of Retinal Physician including a discussion of ergonomics for the retinal physician, private equity pros/cons, and loss to follow-up in patients with macular degeneration and proliferative diabetic retinopathy.
Dr. Sridhar is a consultant for Alcon and has served on advisory boards for Oxurion and Alimera Science. Dr. Kuriyan is a consultant for Allergan, Alimera Science, Bausch health, and Regeneron and has received grant funding from Roche/Genentech and Second Sight. Dr. Yiu is a consultant for Allergan, Alimera Science, Carl Zeiss Meditec, and Iridex and has received grant support from Alcon, Clearside, and Iridex. To claim CME credits for this episode please visit https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio.